drospin midas 3 mg/0.03 mg tabletti, kalvopäällysteinen
midas pharma gmbh - ethinylestradiolum,drospirenonum - tabletti, kalvopäällysteinen - 3 mg/0.03 mg - drospirenoni ja etinyyliestradioli
ranivisio
midas pharma gmbh - ranibitsumabi - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - silmätautien - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
cinacalcet medice 90 mg tabletti, kalvopäällysteinen
medice arzneimittel pütter gmbh & co. kg - cinacalcetum hydrochloridum - tabletti, kalvopäällysteinen - 90 mg - sinakalseetti
prascend 1 mg tabletti
boehringer ingelheim vetmedica gmbh - pergolide mesilate - tabletti - 1 mg - pergolidi
temozolomid ratiopharm 5 mg kapseli, kova
ratiopharm gmbh - temozolomidum - kapseli, kova - 5 mg - temotsolomidi
temozolomid ratiopharm 20 mg kapseli, kova
ratiopharm gmbh - temozolomide - kapseli, kova - 20 mg - temotsolomidi
temozolomid ratiopharm 100 mg kapseli, kova
ratiopharm gmbh - temozolomide - kapseli, kova - 100 mg - temotsolomidi
temozolomid ratiopharm 140 mg kapseli, kova
ratiopharm gmbh - temozolomide - kapseli, kova - 140 mg - temotsolomidi
temozolomid ratiopharm 180 mg kapseli, kova
ratiopharm gmbh - temozolomide - kapseli, kova - 180 mg - temotsolomidi
temozolomid ratiopharm 250 mg kapseli, kova
ratiopharm gmbh - temozolomide - kapseli, kova - 250 mg - temotsolomidi